The MSMO1 gene is crucial for normal brain development, and mutations in this gene can lead to a condition known as microcephaly, characterized by a significantly smaller head size compared to others of the same age and sex. Microcephaly can result in developmental delays, intellectual disabilities, and other neurological complications.
The MSMO1-Related Genetic Test is a specialized diagnostic tool used to identify mutations in the MSMO1 gene that are associated with the development of microcephaly. This test is particularly important for families with a history of the condition or for cases where microcephaly is suspected based on prenatal or postnatal assessments.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The laboratory then analyzes the genetic material to detect any abnormalities in the MSMO1 gene that may indicate a risk or presence of microcephaly.
The cost of the MSMO1-Related Genetic Test at DNA Labs UAE is 4400 AED. While the test price may seem significant, it provides invaluable information for the early diagnosis and management of microcephaly, potentially guiding therapeutic interventions and support to improve the quality of life for affected individuals and their families.
The QARS1 gene microcephaly progressive seizures and cerebral and cerebellar atrophy genetic test is a specialized diagnostic procedure designed to identify mutations in the QARS1 gene, which have been linked to a rare, inherited neurodevelopmental disorder. This condition is characterized by microcephaly (a smaller than normal head size), progressive seizures, and atrophy of the cerebral and cerebellar regions of the brain, leading to significant developmental and neurological challenges.
The test involves analyzing the patient's DNA to detect any genetic anomalies in the QARS1 gene that could be responsible for the symptoms observed. It is a crucial step in confirming a diagnosis, which can then guide treatment options and allow for genetic counseling regarding the condition's inheritance patterns.
Administered at DNA Labs UAE, a leading facility in genetic testing, the cost of this comprehensive test is set at 4400 AED. The lab employs cutting-edge technology and expertise to ensure accurate and reliable results, providing essential information for affected individuals and their families to manage the condition effectively.
The "RTTN Gene Microcephaly Short Stature and Polymicrogyria with Seizures Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RTTN gene. These mutations are associated with a rare genetic disorder that presents with a combination of microcephaly (a condition where the head and brain are significantly smaller than typical for an individual's age and sex), short stature, polymicrogyria (a condition characterized by abnormal development of the brain leading to multiple small folds on the cerebral surface), and seizures.
This test, costing 4400 AED, is crucial for families seeking answers to developmental and neurological issues presenting in infancy or early childhood. By analyzing a sample of the patient's DNA, the test can confirm the presence of the genetic mutation responsible for these symptoms, enabling healthcare professionals to provide a definitive diagnosis. This information is vital for guiding treatment decisions, managing symptoms, and offering genetic counseling for affected families. DNA Labs UAE utilizes state-of-the-art genetic sequencing technologies to ensure accurate and reliable results, making it a trusted choice for genetic testing in the region.
The TUBB2B gene plays a critical role in the proper development and maintenance of the nervous system. Mutations in this gene are associated with a range of neurological conditions, including microcephaly, a condition characterized by a smaller-than-normal head size and potential brain development issues. To diagnose conditions related to TUBB2B mutations, DNA Labs UAE offers a specialized genetic test. Priced at 4400 AED, this test aims to detect alterations in the TUBB2B gene that may lead to microcephaly and other neurological disorders. By identifying such mutations, healthcare providers can offer more accurate diagnoses, better understand the condition's progression, and potentially tailor treatment plans to address specific genetic findings. This test is a crucial tool for families seeking answers about neurodevelopmental disorders linked to the TUBB2B gene.
The YWHAE Gene Miller-Dieker Lissencephaly Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the YWHAE gene, which are associated with Miller-Dieker Lissencephaly Syndrome (MDLS). MDLS is a rare genetic disorder characterized by brain malformations, specifically the smoothness of the cerebral cortex known as lissencephaly, which leads to severe intellectual disability, developmental delay, muscle spasticity, and epilepsy. The YWHAE gene plays a crucial role in brain development, and mutations in this gene can disrupt normal neural patterning, leading to the symptoms observed in MDLS.
This genetic test is essential for confirming the diagnosis of MDLS, enabling early intervention, and providing families with valuable information regarding the prognosis and potential management strategies for affected individuals. It involves analyzing the patient's DNA, extracted from a blood sample, to detect mutations in the YWHAE gene that are indicative of the syndrome.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, offering a wide range of genetic testing services with state-of-the-art technology. The cost of the YWHAE Gene Miller-Dieker Lissencephaly Syndrome Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the specialized technology required, this cost reflects the comprehensive analysis and the detailed, reliable results provided by the lab, which are crucial for affected families seeking answers and support for managing this challenging condition.
The UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the UQCC2 gene, which are associated with Mitochondrial Complex III Deficiency, Nuclear Type 7. This condition is a rare genetic disorder that affects the body's ability to generate energy at the cellular level, leading to a wide range of potential symptoms, including muscle weakness, heart problems, and developmental delays, among others.
Given the complexity and rarity of this condition, accurate diagnosis is crucial for effective management and treatment planning. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any mutations in the UQCC2 gene.
The cost of the UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the advanced technology used in the analysis, and the expertise required to interpret the results accurately. Patients considering this test are advised to consult with a healthcare professional or genetic counselor to understand the implications of the results and to discuss any potential next steps in terms of treatment or management of the condition.
The "PUS1 Gene Mitochondrial Myopathy and Sideroblastic Anemia Type 1 Genetic Test" is a specialized diagnostic examination aimed at identifying mutations in the PUS1 gene, which are associated with a rare genetic condition known as Mitochondrial Myopathy and Sideroblastic Anemia Type 1 (MLASA1). This disorder is characterized by a combination of muscle weakness (myopathy) and a form of anemia in which the bone marrow produces ringed sideroblasts instead of healthy red blood cells. Individuals with this condition may experience a range of symptoms including muscle fatigue, learning difficulties, and physical developmental delays, among others.
The test, which costs 4400 AED, is conducted at DNA Labs UAE, a leading genetic testing facility known for its advanced diagnostic services. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any mutations in the PUS1 gene. This genetic testing is crucial for the accurate diagnosis of MLASA1, enabling affected individuals to receive appropriate management and treatment options. It also provides valuable information for family planning and the assessment of risk in family members.
The CEP57 Gene Mosaic Variegated Aneuploidy Syndrome Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the CEP57 gene, which are linked to Mosaic Variegated Aneuploidy Syndrome Type 2 (MVA Syndrome Type 2). This condition is characterized by a high rate of chromosomal aneuploidy, manifesting in a wide range of clinical symptoms including growth retardation, microcephaly, intellectual disability, and an increased risk of cancer. The test aims to provide a definitive genetic diagnosis for individuals presenting symptoms suggestive of MVA Syndrome Type 2, enabling appropriate clinical management and genetic counseling. Priced at 4400 AED, the test involves collecting a DNA sample from the patient, which is then analyzed for specific mutations in the CEP57 gene that are indicative of the syndrome. This precise genetic testing method helps in the early detection and intervention, potentially improving patient outcomes and providing vital information for family planning decisions.
The TRIM37 Gene Mulibrey Nanism Genetic Test is a specialized diagnostic procedure designed to identify mutations in the TRIM37 gene, which are known to cause Mulibrey Nanism. Mulibrey Nanism is a rare genetic disorder characterized by growth failure, distinctive facial features, and various organ abnormalities. The condition is inherited in an autosomal recessive manner, meaning that a child must inherit two copies of the mutated gene, one from each parent, to be affected.
DNA Labs UAE offers this comprehensive genetic test to help in the diagnosis of Mulibrey Nanism. By analyzing the TRIM37 gene, healthcare providers can confirm the diagnosis, allowing for early intervention and management of the condition. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the TRIM37 gene.
The cost of the TRIM37 Gene Mulibrey Nanism Genetic Test at DNA Labs UAE is 4400 AED. This price may vary based on additional services or consultations required. It's important for patients and families considering this test to consult with their healthcare provider or a genetic counselor to understand the implications of the test results and the best course of action based on those results.
The "PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the PIGN gene, which is known to cause Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 (MCAHS1). MCAHS1 is a rare genetic disorder characterized by a combination of birth defects, muscle weakness (hypotonia), and seizures, among other symptoms. The test is crucial for confirming a diagnosis, understanding the condition's severity, guiding treatment decisions, and providing information for genetic counseling.
This genetic test is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify the genetic alterations within the PIGN gene. By opting for this test at DNA Labs UAE, patients and their families can expect reliable results, which are essential for managing the syndrome effectively and planning for the future.
